Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases

Abstract Neglected Tropical Diseases (NTDs) comprise of a group of seventeen infectious conditions endemic in many developing countries. Among these diseases are three of protozoan origin, namely leishmaniasis, Chagas disease, and African trypanosomiasis, caused by the parasites Leishmania spp., Trypanosoma cruzi, and Trypanosoma brucei respectively. These diseases have their own unique challenges which are associated with the development of effective prevention and treatment methods. Collectively, these parasitic diseases cause more deaths worldwide than all other NTDs combined. Moreover, many current therapies for these diseases are limited in their efficacy, possessing harmful or potentially fatal side effects at therapeutic doses. It is therefore imperative that new treatment strategies for these parasitic diseases are developed. Nanoparticulate drug delivery systems have emerged as a promising area of research in the therapy and prevention of NTDs. These delivery systems provide novel mechanisms for targeted drug delivery within the host, maximizing therapeutic effects while minimizing systemic side effects. Currently approved drugs may also be repackaged using these delivery systems, allowing for their potential use in NTDs of protozoan origin. Current research on these novel delivery systems has provided insight into possible indications, with evidence demonstrating their improved ability to specifically target pathogens, penetrate barriers within the host, and reduce toxicity with lower dose regimens. In this review, we will examine current research on these delivery systems, focusing on applications in the treatment of leishmaniasis, Chagas disease, and African trypanosomiasis. Nanoparticulate systems present a unique therapeutic alternative through the repositioning of existing medications and directed drug delivery.

Saved in:
Bibliographic Details
Main Authors: Volpedo,Greta, Costa,Lourena, Ryan,Nathan, Halsey,Gregory, Satoskar,Abhay, Oghumu,Steve
Format: Digital revista
Language:English
Published: Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP) 2019
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100201
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1678-91992019000100201
record_format ojs
spelling oai:scielo:S1678-919920190001002012019-07-04Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseasesVolpedo,GretaCosta,LourenaRyan,NathanHalsey,GregorySatoskar,AbhayOghumu,Steve Leishmaniasis Chagas Trypanosomiasis Nanoparticles Liposomes Nanotubes Nanodiscs Micelles Abstract Neglected Tropical Diseases (NTDs) comprise of a group of seventeen infectious conditions endemic in many developing countries. Among these diseases are three of protozoan origin, namely leishmaniasis, Chagas disease, and African trypanosomiasis, caused by the parasites Leishmania spp., Trypanosoma cruzi, and Trypanosoma brucei respectively. These diseases have their own unique challenges which are associated with the development of effective prevention and treatment methods. Collectively, these parasitic diseases cause more deaths worldwide than all other NTDs combined. Moreover, many current therapies for these diseases are limited in their efficacy, possessing harmful or potentially fatal side effects at therapeutic doses. It is therefore imperative that new treatment strategies for these parasitic diseases are developed. Nanoparticulate drug delivery systems have emerged as a promising area of research in the therapy and prevention of NTDs. These delivery systems provide novel mechanisms for targeted drug delivery within the host, maximizing therapeutic effects while minimizing systemic side effects. Currently approved drugs may also be repackaged using these delivery systems, allowing for their potential use in NTDs of protozoan origin. Current research on these novel delivery systems has provided insight into possible indications, with evidence demonstrating their improved ability to specifically target pathogens, penetrate barriers within the host, and reduce toxicity with lower dose regimens. In this review, we will examine current research on these delivery systems, focusing on applications in the treatment of leishmaniasis, Chagas disease, and African trypanosomiasis. Nanoparticulate systems present a unique therapeutic alternative through the repositioning of existing medications and directed drug delivery.info:eu-repo/semantics/openAccessCentro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)Journal of Venomous Animals and Toxins including Tropical Diseases v.25 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100201en10.1590/1678-9199-jvatitd-1441-18
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Volpedo,Greta
Costa,Lourena
Ryan,Nathan
Halsey,Gregory
Satoskar,Abhay
Oghumu,Steve
spellingShingle Volpedo,Greta
Costa,Lourena
Ryan,Nathan
Halsey,Gregory
Satoskar,Abhay
Oghumu,Steve
Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
author_facet Volpedo,Greta
Costa,Lourena
Ryan,Nathan
Halsey,Gregory
Satoskar,Abhay
Oghumu,Steve
author_sort Volpedo,Greta
title Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
title_short Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
title_full Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
title_fullStr Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
title_full_unstemmed Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
title_sort nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases
description Abstract Neglected Tropical Diseases (NTDs) comprise of a group of seventeen infectious conditions endemic in many developing countries. Among these diseases are three of protozoan origin, namely leishmaniasis, Chagas disease, and African trypanosomiasis, caused by the parasites Leishmania spp., Trypanosoma cruzi, and Trypanosoma brucei respectively. These diseases have their own unique challenges which are associated with the development of effective prevention and treatment methods. Collectively, these parasitic diseases cause more deaths worldwide than all other NTDs combined. Moreover, many current therapies for these diseases are limited in their efficacy, possessing harmful or potentially fatal side effects at therapeutic doses. It is therefore imperative that new treatment strategies for these parasitic diseases are developed. Nanoparticulate drug delivery systems have emerged as a promising area of research in the therapy and prevention of NTDs. These delivery systems provide novel mechanisms for targeted drug delivery within the host, maximizing therapeutic effects while minimizing systemic side effects. Currently approved drugs may also be repackaged using these delivery systems, allowing for their potential use in NTDs of protozoan origin. Current research on these novel delivery systems has provided insight into possible indications, with evidence demonstrating their improved ability to specifically target pathogens, penetrate barriers within the host, and reduce toxicity with lower dose regimens. In this review, we will examine current research on these delivery systems, focusing on applications in the treatment of leishmaniasis, Chagas disease, and African trypanosomiasis. Nanoparticulate systems present a unique therapeutic alternative through the repositioning of existing medications and directed drug delivery.
publisher Centro de Estudos de Venenos e Animais Peçonhentos (CEVAP/UNESP)
publishDate 2019
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1678-91992019000100201
work_keys_str_mv AT volpedogreta nanoparticulatedrugdeliverysystemsforthetreatmentofneglectedtropicalprotozoandiseases
AT costalourena nanoparticulatedrugdeliverysystemsforthetreatmentofneglectedtropicalprotozoandiseases
AT ryannathan nanoparticulatedrugdeliverysystemsforthetreatmentofneglectedtropicalprotozoandiseases
AT halseygregory nanoparticulatedrugdeliverysystemsforthetreatmentofneglectedtropicalprotozoandiseases
AT satoskarabhay nanoparticulatedrugdeliverysystemsforthetreatmentofneglectedtropicalprotozoandiseases
AT oghumusteve nanoparticulatedrugdeliverysystemsforthetreatmentofneglectedtropicalprotozoandiseases
_version_ 1756429236314308608